Beam Therapeutics: bearish sell signal, week 3
Beam Therapeutics stock: 1.7% bounce fails to break the pattern of lower highs
Beam Therapeutics: bearish sell signal, week 3
Our view last week
Beam Therapeutics stock drops another 8.8% in a week ruled by sellers: buyers nearly vanished and the stock stays deep in a distribution phase. This is the confirmation week for the sell signal, closing lower — our model calls for holding the position unchanged. The sell signal climbs to third among the 141 US stocks on our sell list in this week's technical analysis, with volatility staying very high: opening a position now is high-risk.
This week's summary
Beam Therapeutics stock closes the third week of its Sell signal with a 1.7% bounce, yet the technical sequence stays bearish: three lower highs have marked the decline from the 38 area toward the 27 area. Weekly technical analysis reads signal strength at 27 out of 100 — "a decline losing steam" — with volumes contracting and distribution still pronounced. The stock ranks 39th among the 138 US sell signals, and earnings land in about two weeks.
Sell signal in observation
·3rd week from start
·US stocks
·T2
·📅 Earnings · Aug 11
★ See Gold version →
IQS Phase
84
in tension / maturity
Signal Strength
27
decline losing steam
Sizing
MINIMUM
Ranking
#39 / 138
US stocks sell signals
Trade P&L %
+7.30%
from signal to date, no stop loss
Rank position
ranks 39th among the 138 sell signals for US stocks in our ranking, with a signal strength of 27 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly -0.01% · monthly +1.89%
BEAM belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content